跳至主要内容
临床试验/IRCT20210524051384N10
IRCT20210524051384N10招募中Unknown

Effect of add-on therapy with Ranolazine on reducing tissue ischemia and improvement of clinical outcome in patients with severe burn: A clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age range from 18 to 65 years
  • Acute burn in less than 6 hours
  • Total body surface area (TBSA) between 20 - 50%
  • patients of American Society of Anesthesiologists (ASA) class I (a normal healthy person)
  • Fill out the informed consent

排除标准

  • Having severe hypertension blood pressure (BP) = 160/90 mmHg or systolic pressure below 100 mmHg
  • Ischemic changes in electrocardiogram (ECG)
  • Heart rate less than 70 beats per minute
  • Pregnant women
  • Peripheral vascular disease
  • Presence of inhalation injury
  • Presence of burn shock (including decreased cardiac output, increased vascular resistance, hypovolemia and hypoperfusion following severe burns)
  • Electrical and chemical burns
  • Kidney or liver failure caused by burns (according to the kidney and liver metabolism of the drug)
  • Presence of drug interactions with the patient's previous medications

研究者

发起方
Rasht University of Medical Sciences

相似试验

Effect of add-on therapy with Ranolazine on reducing... | 临床试验